2025
Prevalence of resistance-associated substitutions (RAS) in hepatitis C virus in the Former Soviet Union countries
Mustafa A, Davlidova S, Abidi S, Begimbetova D, Heimer R, Vermund S, Ali S. Prevalence of resistance-associated substitutions (RAS) in hepatitis C virus in the Former Soviet Union countries. BMJ Open Gastroenterology 2025, 12: e001657. PMID: 39848793, PMCID: PMC11758705, DOI: 10.1136/bmjgast-2024-001657.Peer-Reviewed Original ResearchConceptsResistance-associated substitutionsResistance to daclatasvirHepatitis C virusEffective treatment of hepatitis C virusPresence of resistance-associated substitutionsPrevalence of HCV genotype 1bPrevalence of resistance-associated substitutionsC virusNS3 resistance-associated substitutionsNS5B resistance-associated substitutionsEmergence of resistance-associated substitutionsNS5A resistance-associated substitutionsTreatment of hepatitis C virusPrevalence of HCV genotypesDirect-acting antiviralsPrevalence of genotypesEffective treatment regimenHCV genotype 1bHCV-infected individualsSequences of hepatitis C virusTreatment regimenHCV genotypesGenotype 1bGenotype 3aEffective treatment
2020
Transmission of HIV and HCV within Former Soviet Union Countries
Aibekova L, Bexeitova A, Aldabergenova A, Hortelano G, Ge Z, Yi F, Shao Y, DeHovitz J, Vermund SH, Ali S. Transmission of HIV and HCV within Former Soviet Union Countries. Canadian Journal Of Gastroenterology And Hepatology 2020, 2020: 9701920. PMID: 32733822, PMCID: PMC7378597, DOI: 10.1155/2020/9701920.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusHepatitis C virusBlood-borne infectionsTransmission of HIVInjection drug useBlood-borne virusesHigh-risk populationInjection drug usersHarm reduction effortsOrigin of infectionImmunodeficiency virusC virusFSU countriesDrug usersDrug useHIV sequencesInfectionFormer Soviet Union countriesSoviet Union countriesVirusMajor populationPopulation